Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

NCT00448253 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Symptoms of Inhalational Anthrax

Interventions

BIOLOGICAL: NP-015

Sponsor

Emergent BioSolutions

Collaborators

[object Object]